Sacral and tibial nerve stimulation to improve bladder function after recent suprasacral spinal cord injury
Official title: Effectiveness of Transcutaneous Tibial and Sacral Nerve Stimulation in Preventing the Development of Detrusor Overactivity in Patients With Subacute Suprasacral Spinal Cord Injury
Run by Ankara City Hospital Bilkent · NCT07343583 · Data updated 2026-11-12
This trial will test whether noninvasive sacral or tibial nerve stimulation can prevent or reduce overactive bladder in adults within six months of a suprasacral spinal cord injury.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 45 (estimated) |
| Sponsor | Ankara City Hospital Bilkent Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Ankara, Çankaya) |
| Status | Recruiting |
| Started | August 5, 2025 |
| Main results expected | March 1, 2026 |
| Study ends | April 1, 2026 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT07343583 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18–65 with a suprasacral (above T11) spinal cord injury of less than six months' duration who do not have pacemakers, active urinary infection, other neurologic diseases affecting the bladder, prior pelvic radiation or bladder surgery, or medications that alter bladder function.
✕Probably not a fit
Patients with chronic (>6 months) or lower motor neuron spinal injuries, structural genitourinary abnormalities, active urinary tract infection, prior neuromodulation after injury, pacemakers, or other excluded conditions are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with traumatic or non‑traumatic suprasacral spinal cord injury (within six months of injury and above T11) are randomly assigned to transcutaneous tibial nerve stimulation (TTNS), transcutaneous sacral nerve stimulation (TSNS), or standard care without neuromodulation. Intervention groups receive 15 sessions of noninvasive neuromodulation, with urodynamic evaluations used to measure detrusor activity and bladder pressures before and after the intervention period. The protocol compares the two stimulation sites to determine which, if either, better prevents development or progression of neurogenic detrusor overactivity in the subacute phase. Outcomes focus on objective urodynamic measures and clinically relevant bladder symptoms.
Why it matters
Potential benefit: If successful, these noninvasive approaches could reduce urinary incontinence and high bladder storage pressures, lowering the risk of kidney damage and the need for medications or invasive procedures.
How similar studies have gone: Transcutaneous tibial nerve stimulation has shown benefit in some neurogenic and non‑neurogenic bladder disorders, while transcutaneous sacral stimulation is less well studied and comparative data in subacute SCI are currently lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. ≥18-65 years of age 2. Injury duration \<6 months 3. Traumatic and non-traumatic SCI; 4. Patients with spinal cord injury above T11 Exclusion Criteria: 1. Patients with a cardiac pacemaker 2. Patients with other neurological diseases that may affect neurogenic bladder (Parkinson's disease, polyneuropathy, neurodegenerative disease, cerebrovascular disease, etc.) 3. Patients with structural abnormalities in the genitourinary system (pelvic floor dysfunction, BPH, etc.) 4. Patients with acute urinary tract infection 5. Patients with a history of pelvic fracture associated with SCI 6. Patients using medications that may affect NDO (anticholinergic-sympathomimetic, etc.) 7. Patients who have undergone another neuromodulation technique after injury 8. Patients who have previously undergone pelvic radiation, bladder cancer, or other surgical procedures performed on the bladder that may affect bladder physiology will not be included in the study.
Where it's running
-
Ankara Bilkent City Hospital
Ankara, Çankaya, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Zuhal Özişler, associate professor — Ankara City Hospital Bilkent
- Study coordinator: Zeynep S Güneş
- Email: gnszeynp19@gmail.com
- Phone: +905545263535
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Implanted Brain-Computer Interface to Help People with Severe Arm Impairment
We’re testing the N1 System, a fully implanted brain interface in the motor cortex with a robot, to see if it can help adults with spinal cord injury, ALS, or chronic stroke use a computer or keyboard more easily.
-
tSCS with rehabilitation for improving movement after spinal cord injury
This study tests whether adding rehabilitation training to transcutaneous spinal cord stimulation helps paraplegic patients regain voluntary movement after spinal cord injury.
-
Informational Needs of Caregivers of Patients in Neuro Rehab: Validating the QBI-R/V
This study tests a caregiver questionnaire (QBI-R and QBI-V) to see how well it measures caregivers’ informational needs during neuromotor rehabilitation.
-
Biomechanical and Perceived Effort in Manual Wheelchair Propulsion
This study tests whether combining objective shoulder loading data with how hard people feel they’re working can reveal how difficult manual wheelchair propulsion is for users with spinal cord injury.
-
Shockwave therapy added to toxin injections to help spasticity after spinal cord injury
Aims to see if focused shockwave therapy plus Botox injections reduce spasticity better than Botox alone in adults with spinal cord injury.
-
Vibratory Genital Nerve Stimulation to Help Female Sexual Function After Spinal Cord Injury
This study tests whether a home-use vibration device can improve sexual function in cisgender women with spinal cord injury by increasing genital blood flow during arousal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.